Condition
Delayed Graft Function clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Delayed Graft Function clinical trials that are recruiting, at sites in 18 countries (most in China (2), United States (2), Canada (2)). By phase: Phase 1/2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 18Countries
Newest Delayed Graft Function clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Intraoperative diuretics during deceased-donor kidney transplants | — | London, Ontario and 1 other locations | Recruiting | Jul 24, 2026 |
| Vonoprazan to reduce delayed graft function after deceased-donor kidney transplant | Phase 1/2 | Chongqing and 1 other locations | Recruiting | Dec 10, 2025 |
| Evaluating Ravulizumab for Reducing Delayed Graft Function After Kidney Transplant | Phase 3 | Phoenix, Arizona and 129 other locations | Recruiting | Feb 17, 2025 |
| Using Treprostinil to Reduce Kidney Injury During Transplantation | Phase 1/2 | Providence, Rhode Island | Recruiting | Jul 2, 2019 |
All recruiting trials (4)
-
Intraoperative diuretics during deceased-donor kidney transplants
This trial tests whether using furosemide or mannitol during kidney transplant surgery affects delayed graft function in adults receiving a deceased-donor kidney.
-
Vonoprazan to reduce delayed graft function after deceased-donor kidney transplant
This trial will test whether giving vonoprazan around the time of surgery lowers the chance of delayed graft function in adults receiving their first deceased-donor kidney transplant.
-
Evaluating Ravulizumab for Reducing Delayed Graft Function After Kidney Transplant
This study is testing if a new drug called ravulizumab can help kidney transplant patients avoid delayed graft function and reduce the need for dialysis.
-
Using Treprostinil to Reduce Kidney Injury During Transplantation
This study is testing if a medication called treprostinil can help protect the kidneys of adults getting a transplant from deceased donors and improve their recovery.
Related topics
Quick answers
How many Delayed Graft Function clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 18 countries. The most sites are in China (2 trials), United States (2 trials), Canada (2 trials), Argentina (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.